Advanced search
Publication Cover
Modern Rheumatology Volume 23, 2013 - Issue 2
Journal homepage
114
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI)

Naoto YokogawaDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8524, JapanCorrespondence[email protected]
,
Akiko TanikawaDepartment of Dermatology, Keio University School of Medicine, Tokyo, Japan
,
Masayuki AmagaiDepartment of Dermatology, Keio University School of Medicine, Tokyo, Japan
,
Yukihiko KatoDepartment of Dermatology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan
,
Yoko MomoseDepartment of Dermatology, St. Luke’s International Hospital, Tokyo, Japan
,
Satoru AraiDepartment of Dermatology, St. Luke’s International Hospital, Tokyo, Japan
,
Hikaru EtoDepartment of Dermatology, St. Luke’s International Hospital, Tokyo, Japan
,
Takaharu IkedaDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan
&
Fukumi FurukawaDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan
 show all
Pages 318-322 | Received 02 Mar 2012, Accepted 16 Apr 2012, Published online: 02 Jan 2014

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

C. Ponticelli & G. Moroni. (2017) Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opinion on Drug Safety 16:3, pages 411-419.
Read now
Fukumi Furukawa. (2014) Practical therapeutics for skin lesions of Japanese patients with discoid lupus erythematosus. Expert Opinion on Orphan Drugs 2:5, pages 477-482.
Read now

Articles from other publishers (22)

Danaë A. Papachristos, Dafna D. Gladman, Jiandong Su & Murray B. Urowitz. (2022) Outcomes following antimalarial withdrawal in patients with quiescent systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 55, pages 152046.
Crossref
D. Peh, W. S. L. Wan Ahmad Kammal, P. J. Beh, A. C. H. Yong, W. C. Tan, A. L. Lim, S. Thevarajah, J. Stanslas & Kang Nien How. (2022) Correlation of whole blood hydroxychloroquine concentration with cutaneous lupus erythematosus and factors associated with it: First multicenter, cross‐sectional analysis in Malaysia. The Journal of Dermatology 49:5, pages 545-549.
Crossref
Alina Dima, Ciprian Jurcut, François Chasset, Renaud Felten & Laurent Arnaud. (2022) Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2110730.
Crossref
Mai Yoshida, Kentaro Minowa, Hirofumi Amano, Yuki Asai, Ken Yamaji & Naoto Tamura. (2021) Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus. Lupus 30:9, pages 1378-1384.
Crossref
Bahman Amani, Ahmad Khanijahani & Behnam Amani. (2021) Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials. Scientific Reports 11:1.
Crossref
Manabu Fujimoto, Jun Asai, Yoshihide Asano, Takayuki Ishii, Yohei Iwata, Tamihiro Kawakami, Masanari Kodera, Masatoshi Abe, Masahiro Amano, Ryuta Ikegami, Taiki Isei, Zenzo Isogai, Takaaki Ito, Yuji Inoue, Ryokichi Irisawa, Masaki Ohtsuka, Yoichi Omoto, Hiroshi Kato, Takafumi Kadono, Sakae Kaneko, Hiroyuki Kanoh, Masakazu Kawaguchi, Ryuichi Kukino, Takeshi Kono, Monji Koga, Keisuke Sakai, Eiichi Sakurai, Yasuko Sarayama, Yoichi Shintani, Miki Tanioka, Hideaki Tanizaki, Jun Tsujita, Naotaka Doi, Takeshi Nakanishi, Akira Hashimoto, Minoru Hasegawa, Masahiro Hayashi, Kuninori Hirosaki, Hideki Fujita, Hiroshi Fujiwara, Takeo Maekawa, Koma Matsuo, Naoki Madokoro, Sei‐Ichiro Motegi, Hiroshi Yatsushiro, Osamu Yamasaki, Yuichiro Yoshino, Andres James LE Pavoux, Takao Tachibana & Hironobu Ihn. (2020) Wound, pressure ulcer and burn guidelines – 4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers. The Journal of Dermatology 47:10, pages 1071-1109.
Crossref
Akane Nagasato, Masato Hamabashiri, Yukari Ono, Hitoshi Nakashima, Katsuhisa Miyake, Naoko Himuro & Hidetoshi Kamimura. (2020) Three Cases of Drug Discontinuation due to Adverse Events in Systemic Lupus Erythematosus Patients Administered Hydroxychloroquine. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 46:3, pages 146-152.
Crossref
William D. Shipman, Nicholas A. Vernice, Michelle Demetres & Joseph L. Jorizzo. (2020) An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review. Journal of the American Academy of Dermatology 82:3, pages 709-722.
Crossref
J.L. Fairley, S. Oon, A.M. Saracino & M. Nikpour. (2020) Management of cutaneous manifestations of lupus erythematosus: A systematic review. Seminars in Arthritis and Rheumatism 50:1, pages 95-127.
Crossref
K Takezawa, I Ueda-Hayakawa, F Yamazaki, N Kambe, Y Son & H Okamoto. (2019) Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction. Lupus 29:1, pages 79-82.
Crossref
Dorian Parisis, Charlie Bernier, François Chasset & Laurent Arnaud. (2019) Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmunity Reviews 18:11, pages 102393.
Crossref
Mayumi Kamaguchi, Hiroaki Iwata, Takuya Asaka, Hiroshi Shimizu & Yoshimasa Kitagawa. (2019) Mucosal lesions in cutaneous lupus erythematosus successfully treated with hydroxychloroquine. Oral Science International 16:2, pages 106-109.
Crossref
François Chasset & Camille Francès. (2019) Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review. Drugs 79:11, pages 1199-1215.
Crossref
Yasushi Ototake, Yukie Yamaguchi, Miwa Kanaoka, Asami Akita, Nobuaki Ikeda & Michiko Aihara. (2019) Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients. The Journal of Dermatology 46:4, pages 285-289.
Crossref
Chikako Kishi, Sei-ichiro Motegi, Masahito Yasuda & Osamu Ishikawa. (2018) Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients. The Journal of Dermatology 45:8, pages 1020-1022.
Crossref
Caroline GordonMaame-Boatemaa Amissah-ArthurMary GayedSue BrownIan N. BruceDavid D’CruzBenjamin EmpsonBridget GriffithsDavid JayneMunther KhamashtaLiz LightstonePeter Norton, Yvonne Norton, Karen SchreiberDavid Isenberg. (2018) The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology 57:1, pages e1-e45.
Crossref
F. Chasset, J.-D. Bouaziz, N. Costedoat-Chalumeau, C. Francès & L. Arnaud. (2017) Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis. British Journal of Dermatology 177:1, pages 188-196.
Crossref
N. Yokogawa, H. Eto, A. Tanikawa, T. Ikeda, K. Yamamoto, T. Takahashi, H. Mizukami, T. Sato, N. Yokota & F. Furukawa. (2017) Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double‐Blind, Randomized, Parallel‐Group Trial. Arthritis & Rheumatology 69:4, pages 791-799.
Crossref
François Chasset, Camille Francès, Stéphane Barete, Zahir Amoura & Laurent Arnaud. (2015) Influence of smoking on the efficacy of antimalarials in cutaneous lupus: A meta-analysis of the literature. Journal of the American Academy of Dermatology 72:4, pages 634-639.
Crossref
. (2015) Hydroxychloroquine. Reactions Weekly 1548:1, pages 133-133.
Crossref
Toshiyuki Yamamoto & Tomoko Hiraiwa. (2014) Beneficial effect of hydroxychloroquine on cutaneous lupus erythematosus in a Japanese girl. The Journal of Dermatology 41:4, pages 357-359.
Crossref
M Ishiguro, H Hashizume, T Ikeda, Y Yamamoto & F Furukawa. (2013) Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan. Lupus 23:1, pages 93-101.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.